Pfizer Licenses Families of Spinal Muscular Atrophy Quinazoline Drug Program From Repligen ELK GROVE VILLAGE, Ill., Jan. 3, 2013 (GLOBE NEWSWIRE) -- Repligen Corporation announced today that it has entered into an exclusive worldwide licensing agreement with Pfizer Inc. to advance...